COMMUNIQUÉ DE PRESSE publié le 20/08/2024 à 16:00, il y a 1 mois Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award Jaguar Health announces Eduardo Zimmer as 2024 Blas Frangione Early Career Achievement Award recipient for work with Magdalena Biosciences on plant-based mental health medicines Mental Health Jaguar Health Magdalena Biosciences Plant-based Medicines Eduardo Zimmer
BRÈVE publiée le 12/08/2024 à 16:05, il y a 1 mois 8 jours Jaguar Health organise un webcast pour les investisseurs le 13 août Crofelemer Essai De Phase 3 Résultats Financiers Du Deuxième Trimestre Webcast Pour Les Investisseurs Diarrhée Liée Au Traitement Du Cancer
BRÈVE publiée le 12/08/2024 à 16:05, il y a 1 mois 8 jours Jaguar Health to Host Investor Webcast on August 13th Crofelemer Investor Webcast Cancer Therapy-related Diarrhea Phase 3 Trial Q2 Financials
COMMUNIQUÉ DE PRESSE publié le 12/08/2024 à 16:00, il y a 1 mois 8 jours REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients Jaguar Health plans crofelemer approval pathway for breast and lung cancer based on phase 3 results. Join the investor webcast on August 13, 2024, for financial & corporate updates Crofelemer Investor Webcast FDA Approval Jaguar Health Phase 3 Results
BRÈVE publiée le 05/08/2024 à 16:23, il y a 1 mois 15 jours Jaguar Health to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Crofelemer Jaguar Health OnTarget Trial Breast Cancer Lung Cancer
BRÈVE publiée le 05/08/2024 à 16:23, il y a 1 mois 15 jours Jaguar Health va explorer la voie d'approbation du Crofelemer dans le traitement du cancer du sein et du poumon Crofelemer Santé Jaguar Essai OnTarget Cancer Du Sein Cancer Du Poumon
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 16:18, il y a 1 mois 15 jours Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningf Jaguar Health, Inc. issued a letter to shareholders regarding the upcoming webcast to review second-quarter earnings and clinical data from the recent phase 3 OnTarget trial of crofelemer for breast and lung cancer patients Crofelemer Webcast Jaguar Health Breast Cancer Lung Cancer
BRÈVE publiée le 02/08/2024 à 16:05, il y a 1 mois 18 jours Elaine Elisabetsky, PhD, to Discuss Plant-Based Schizophrenia Treatments Jaguar Health Magdalena Biosciences Schizophrenia Plant-based Medicine Ethnopharmacology
BRÈVE publiée le 02/08/2024 à 16:05, il y a 1 mois 18 jours Elaine Elisabetsky, PhD, discutera des traitements contre la schizophrénie à base de plantes Magdalena Biosciences Schizophrénie Santé Jaguar Médecine À Base De Plantes Ethnopharmacologie
COMMUNIQUÉ DE PRESSE publié le 02/08/2024 à 16:00, il y a 1 mois 18 jours Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy Dr. Elisabetsky conducts research on plant-based medicines for mental health conditions. Jaguar out-licenses botanical drug for schizophrenia treatment to Magdalena Biosciences Jaguar Health Magdalena Biosciences Schizophrenia Dr. Elisabetsky Plant-based Medicines
Publié le 20/09/2024 à 17:40, il y a 17 heures 10 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 17 heures 10 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 11 heures 10 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 11 heures 20 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 11 heures 50 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 12 heures 20 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 12 heures 35 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 21/09/2024 à 09:48, il y a 1 heure 1 minute EQS-Adhoc: Nakiki SE: Mask lawsuits will not be financed
Publié le 20/09/2024 à 22:58, il y a 11 heures 51 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 13 heures 50 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 14 heures 35 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 14 heures 59 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator